A Guide to Good Distribution Practice (GDP) in Saudi Arabia and Beyond

Published: March 2025

By Wattam Logistics Team

What is Good Distribution Practice?

Good Distribution Practice (GDP) is a set of internationally recognized standards that govern the sourcing, handling, storage, and transportation of medicines and other sensitive products. Its goal is to ensure that products arrive at their destination in the same safe and effective condition as when they left the manufacturer.

GDP is part of the wider "Good Practices" framework that includes Good Manufacturing Practice (GMP) and Good Storage Practice (GSP). Together, these principles protect patients, prevent counterfeit medicines from entering supply chains, and maintain public trust.

GDP in Saudi Arabia

In Saudi Arabia, the Saudi Food and Drug Authority (SFDA) regulates pharmaceutical distribution under strict GDP and GSP standards. Distributors, logistics providers, and wholesalers must comply with SFDA licensing requirements, which align with global frameworks such as WHO, EMA, and MHRA.

For companies operating in the Kingdom, GDP compliance is not optional. It is a prerequisite for obtaining SFDA approval to distribute medicines, vaccines, and other medical products. This ensures that products remain safe across the supply chain — from manufacturer, through refrigerated trucks and warehouses, to hospitals and pharmacies.

At Wattam Logistics, we meet these requirements by:

Operating a fleet of temperature-controlled trucks for cold chain transport (+2°C to +8°C for vaccines, -20°C for frozen products, etc.)

Using calibrated sensors and live tracking to monitor shipments in real time

Providing full end-to-end traceability reports for every delivery

Maintaining SFDA licensing and compliance as proof of quality and reliability

GDP in the UK and EU

**European Union (EU):** GDP is enforced by national authorities under EU Commission guidelines. Wholesale distributors require GDP certification to operate legally. Certificates are usually granted within 90 days of a successful inspection.

**United Kingdom (UK):** The Medicines and Healthcare products Regulatory Agency (MHRA) regulates GDP. Certification is only issued once inspectors confirm compliance with corrective measures.

Saudi Arabia mirrors these global practices through the SFDA, ensuring that local logistics providers operate at international standards.

Why GDP is Important

The pharmaceutical supply chain is fragile and mistakes are costly. GDP is critical because:

**Patient safety comes first.** Improper handling or temperature excursions can make medicines ineffective or harmful.

**It prevents falsified medicines.** GDP provides safeguards against counterfeit or substandard products entering the market.

**It ensures continuity of supply.** Proper storage and transport reduce shortages and delays.

**It protects reputation.** Non-compliance can destroy trust and bring heavy regulatory penalties.

For Saudi Arabia, GDP is central to Vision 2030's healthcare transformation goals, ensuring that patients nationwide receive safe and effective treatments.

Who Needs GDP Certification?

**In Saudi Arabia:** Any company handling, storing, or transporting medicines must be licensed by the SFDA and comply with GDP.

**In the EU/EEA:** All wholesale distributors of medicines require GDP certification.

**In the UK:** Any distributor supplying medicines beyond end-users must hold GDP certification.

Without certification, companies cannot legally participate in the medical supply chain.

What is GDP Training?

GDP training ensures that every person in the supply chain understands their responsibilities. Training typically covers:

Secure handling and storage

Product identification and traceability

Detecting falsified or counterfeit medicines

Preventing supply chain breaches

In Saudi Arabia, the Responsible Person (RP) within a logistics or wholesale company is tasked with overseeing GDP training and ensuring staff remain compliant with SFDA and WHO guidelines.

Key Principles of GDP

The WHO, EU, and SFDA GDP guidelines emphasize:

**Quality Management:** Written quality policies, SOPs, and audits.

**Qualified Personnel:** Staff trained and supervised by a Responsible Person.

**Premises & Storage:** Secure, clean warehouses with temperature and humidity controls; FEFO ("First Expired, First Out") applied.

**Transportation:** Vehicles equipped to maintain conditions, with validated monitoring systems.

**Documentation & Traceability:** Records kept for at least 7 years, enabling full recall if necessary.

**Supplier & Customer Checks:** Only trading with SFDA-authorized partners.

**Complaints, Returns & Recalls:** Written processes for handling issues.

**Counterfeit Prevention:** Suspected falsified products quarantined and reported.

**Self-Inspection:** Regular internal audits to maintain compliance.

Beyond Compliance: The Benefits of GDP

For Saudi logistics companies like Wattam Logistics, GDP compliance delivers real advantages:

**Reliability:** Trusted by hospitals, pharmacies, and regulators.

**Market access:** Required for SFDA tenders and international partnerships.

**Risk reduction:** Minimizes spoilage, recalls, and penalties.

**Reputation:** Positions Saudi providers as global-standard players.

Conclusion

Good Distribution Practice (GDP) is more than a regulatory obligation — it's a commitment to public health, quality, and professionalism.

In Saudi Arabia, GDP compliance ensures that patients receive safe medicines, protects the healthcare system from counterfeit products, and strengthens the Kingdom's role in global pharma logistics.

At Wattam Logistics, we uphold these standards with pride, ensuring that every shipment — whether local or international — meets SFDA, WHO, and global GDP benchmarks.

A Guide to Good Distribution Practice (GDP) in Saudi Arabia and Beyond